Cargando…

Argininosuccinate synthase 1 is an intrinsic Akt repressor transactivated by p53

The transcription factor p53 is at the core of a built-in tumor suppression system that responds to varying degrees of stress input and is deregulated in most human cancers. Befitting its role in maintaining cellular fitness and fidelity, p53 regulates an appropriate set of target genes in response...

Descripción completa

Detalles Bibliográficos
Autores principales:	Miyamoto, Takafumi, Lo, Paulisally Hau Yi, Saichi, Naomi, Ueda, Koji, Hirata, Makoto, Tanikawa, Chizu, Matsuda, Koichi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Association for the Advancement of Science 2017
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5438217/ https://www.ncbi.nlm.nih.gov/pubmed/28560349 http://dx.doi.org/10.1126/sciadv.1603204

Ejemplares similares

Identification of a novel p53 target, COL17A1, that inhibits breast cancer cell migration and invasion
por: Yodsurang, Varalee, et al.
Publicado: (2017)

Cystatin C as a p53‐inducible apoptotic mediator that regulates cathepsin L activity
por: Mori, Jinichi, et al.
Publicado: (2016)

Regulation of iron homeostasis by the p53-ISCU pathway
por: Funauchi, Yuki, et al.
Publicado: (2015)

INKA2, a novel p53 target that interacts with the serine/threonine kinase PAK4
por: Liu, Yu-Yu, et al.
Publicado: (2019)

EPSIN 3, A Novel p53 Target, Regulates the Apoptotic Pathway and Gastric Carcinogenesis()
por: Mori, Jinichi, et al.
Publicado: (2017)

Identification of a p53-repressed gene module in breast cancer cells
por: Miyamoto, Takafumi, et al.
Publicado: (2017)

Identification of a Functional Variant in the MICA Promoter Which Regulates MICA Expression and Increases HCV-Related Hepatocellular Carcinoma Risk
por: Lo, Paulisally Hau Yi, et al.
Publicado: (2013)

Argininosuccinate synthase 1, arginine deprivation therapy and cancer management
por: Sun, Naihui, et al.
Publicado: (2022)

Identification of a p53 target, CD137L, that mediates growth suppression and immune response of osteosarcoma cells
por: Tsuda, Yusuke, et al.
Publicado: (2017)

Leishmania donovani Argininosuccinate Synthase Is an Active Enzyme Associated with Parasite Pathogenesis
por: Lakhal-Naouar, Ines, et al.
Publicado: (2012)

Inhibition of the Polyamine Synthesis Pathway Is Synthetically Lethal with Loss of Argininosuccinate Synthase 1
por: Locke, Matthew, et al.
Publicado: (2016)

A pan-cancer analysis of the role of argininosuccinate synthase 1 in human tumors
por: Ding, Qiang, et al.
Publicado: (2023)

Downregulation of the tumor suppressor HSPB7, involved in the p53 pathway, in renal cell carcinoma by hypermethylation
por: LIN, JIAYING, et al.
Publicado: (2014)

Late Cornified Envelope Group I, a Novel Target of p53, Regulates PRMT5 Activity()
por: Deng, Zhenzhong, et al.
Publicado: (2014)

Genetic Manipulation of Leishmania donovani to Explore the Involvement of Argininosuccinate Synthase in Oxidative Stress Management
por: Sardar, Abul Hasan, et al.
Publicado: (2016)

Extracellular vesicles from human liver stem cells restore argininosuccinate synthase deficiency
por: Herrera Sanchez, Maria Beatriz, et al.
Publicado: (2017)

Epigenetic status of argininosuccinate synthetase and argininosuccinate lyase modulates autophagy and cell death in glioblastoma
por: Syed, N, et al.
Publicado: (2013)

Heterologous Expression of Argininosuccinate Synthase From Oenococcus oeni Enhances the Acid Resistance of Lactobacillus plantarum
por: Zhao, Hongyu, et al.
Publicado: (2019)

Naturally-occurring spinosyn A and its derivatives function as argininosuccinate synthase activator and tumor inhibitor
por: Zou, Zizheng, et al.
Publicado: (2021)

Retraction: Genetic Manipulation of Leishmania donovani to Explore the Involvement of Argininosuccinate Synthase in Oxidative Stress Management
Publicado: (2023)

Collagen XVII inhibits breast cancer cell proliferation and growth through deactivation of the AKT/mTOR signaling pathway
por: Lothong, Muttarin, et al.
Publicado: (2021)

Argininosuccinate Synthase 1-Deficiency Enhances the Cell Sensitivity to Arginine through Decreased DEPTOR Expression in Endometrial Cancer
por: Ohshima, Kenji, et al.
Publicado: (2017)

Long-Range Modulation of Chain Motions within the Intrinsically Disordered Transactivation Domain of Tumor Suppressor p53
por: Lum, Jenifer K., et al.
Publicado: (2011)

The Transcriptional Landscape of p53 Signalling Pathway
por: Tanikawa, Chizu, et al.
Publicado: (2017)

Regression based predictor for p53 transactivation
por: Gowrisankar, Sivakumar, et al.
Publicado: (2009)

Novel mutations underlying argininosuccinic aciduria in Saudi Arabia
por: Imtiaz, Faiqa, et al.
Publicado: (2010)

Expanding the phenotype in argininosuccinic aciduria: need for new therapies
por: Baruteau, Julien, et al.
Publicado: (2017)

Epithelial argininosuccinate synthetase is dispensable for intestinal regeneration and tumorigenesis
por: van der Meer, Jonathan H. M., et al.
Publicado: (2021)

Wide-line NMR and DSC studies on intrinsically disordered p53 transactivation domain and its helically pre-structured segment
por: Tompa, Peter, et al.
Publicado: (2016)

Argininosuccinate lyase interacts with cyclin A2 in cytoplasm and modulates growth of liver tumor cells
por: Hung, Yu-Hsuan, et al.
Publicado: (2017)

Computational strategy for intrinsically disordered protein ligand design leads to the discovery of p53 transactivation domain I binding compounds that activate the p53 pathway
por: Ruan, Hao, et al.
Publicado: (2020)

The Transcriptional Repressor Domain of Gli3 Is Intrinsically Disordered
por: Tsanev, Robert, et al.
Publicado: (2013)

The Relationship of Arginine Deprivation, Argininosuccinate Synthetase and Cell Death in Melanoma
por: Savaraj, Niramol, et al.
Publicado: (2007)

A transgenic approach to study argininosuccinate synthetase gene expression
por: Shiue, Shih-Chang, et al.
Publicado: (2014)

Refeeding syndrome in a young woman with argininosuccinate lyase deficiency()
por: Stuy, M., et al.
Publicado: (2015)

Identification of mutations in Malaysian patients with argininosuccinate lyase (ASL) deficiency
por: Ali, Ernie Zuraida, et al.
Publicado: (2019)

Argininosuccinate lyase is a metabolic vulnerability in breast development and cancer
por: Karvelsson, Sigurdur Trausti, et al.
Publicado: (2021)

Lentiviral vectors encoding tetracycline-dependent repressors and transactivators for reversible knockdown of gene expression: a comparative study
por: Pluta, Krzysztof, et al.
Publicado: (2007)

Soluble MICA and a MICA Variation as Possible Prognostic Biomarkers for HBV-Induced Hepatocellular Carcinoma
por: Kumar, Vinod, et al.
Publicado: (2012)

Argininosuccinate synthase 1 suppresses tumor progression through activation of PERK/eIF2α/ATF4/CHOP axis in hepatocellular carcinoma
por: Kim, Sanghwa, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_p59073vb1mpjcgc8ppt1dfp5c5